GRIA1 and Alzheimer disease: Previous analyses of hippocampal postsynaptic density fractions from human AD patients showed an increase in GluA1 levels compared to healthy controls, whereas no changes in NMDAR subunit expression were observed [41], suggesting a selective increase in GluA1-containing receptors in the hippocampus of AD patients.